U.S. Professional Services Stock News

Terra Innovatum Global (NasdaqGM:NKLR) has just been added to the NASDAQ Composite Index, a move that often draws new attention from both institutional and individual investors. As its visibility expands, the company is making headlines with its SOCLO micro-modular reactor, an effort that aims to change how medical isotopes are supplied for cancer care. See our latest analysis for Terra Innovatum Global. Terra Innovatum Global’s 1-day share price return of 16.98% and a stunning 75.92% surge...

As the U.S. stock market navigates a landscape marked by strong bank earnings and renewed trade tensions with China, investors are keeping a close eye on potential opportunities amidst the volatility. In this environment, identifying undervalued stocks can be crucial for those seeking to capitalize on discrepancies between market prices and intrinsic value.

As the U.S. stock market shows resilience amidst big bank earnings and ongoing trade tensions with China, investors continue to seek opportunities across various sectors. Penny stocks, though often seen as a relic of past trading days, remain a relevant investment area due to their potential for growth at lower price points. These smaller or newer companies can offer significant upside when they have strong financials and fundamentals, making them an intriguing option for those looking to...

With a price-to-earnings (or "P/E") ratio of 9.4x Beazer Homes USA, Inc. ( NYSE:BZH ) may be sending bullish signals at...

Key Insights Yatsen Holding's significant insider ownership suggests inherent interests in company's expansion 53% of...

In recent days, the U.S. stock market has experienced significant volatility, with major indices like the Nasdaq and S&P 500 rebounding sharply following a softer tone from President Trump on trade tensions with China. This environment of fluctuating market sentiment underscores the potential opportunities within small-cap stocks, particularly those that may be undervalued and are experiencing insider buying. Identifying such stocks requires a keen understanding of market dynamics and...

As of October 2025, the U.S. stock market has been experiencing significant volatility, with major indices like the Nasdaq and S&P 500 rebounding sharply after recent declines due to geopolitical tensions. This dynamic environment underscores the importance of identifying high-growth tech stocks that can capitalize on evolving market conditions, particularly those demonstrating resilience and innovation in response to global economic shifts.

Amid recent market volatility, the U.S. stock indices have experienced significant fluctuations, with a notable surge following President Trump's softened stance on China. As investors navigate these turbulent times, identifying stocks that are potentially undervalued can present opportunities for those looking to capitalize on discrepancies between market prices and intrinsic values.

As the United States market experiences a notable upswing, with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average closing higher following positive developments in U.S.-China relations, investors are keenly observing potential opportunities. Penny stocks may be a throwback term, but the opportunities they represent are far from old news. These smaller or newer companies can offer significant growth potential when supported by strong financials and solid fundamentals. In...

To the annoyance of some shareholders, Q2 Holdings, Inc. ( NYSE:QTWO ) shares are down a considerable 25% in the last...

Richardson Electronics reported its first quarter 2026 results on October 8, 2025, posting sales of US$54.61 million and net income of US$1.91 million, both higher than the same period last year, and reaffirmed its quarterly dividend of US$0.06 per common share and US$0.054 per Class B share. These results reflect both revenue and earnings growth paired with continued shareholder returns, highlighting stronger profitability and an ongoing commitment to dividends. With the earnings growth...

Key Insights Using the 2 Stage Free Cash Flow to Equity, MoneyHero fair value estimate is US$2.54 Current share price...

Key Insights Using the 2 Stage Free Cash Flow to Equity, VTEX fair value estimate is US$5.05 With US$4.22 share price...

Eton Pharmaceuticals, Inc. ( NASDAQ:ETON ) shareholders might be concerned after seeing the share price drop 13% in the...

Assembly Biosciences, Inc. ( NASDAQ:ASMB ) insiders who purchased shares in the last 12 months were richly rewarded...

While Kronos Worldwide, Inc. ( NYSE:KRO ) might not have the largest market cap around , it received a lot of attention...

With its stock down 22% over the past three months, it is easy to disregard Loma Negra Compañía Industrial Argentina...

We think all investors should try to buy and hold high quality multi-year winners. And highest quality companies can...

The last three months have been tough on Pro-Dex, Inc. ( NASDAQ:PDEX ) shareholders, who have seen the share price...

Constellation Brands, Inc.'s ( NYSE:STZ ) solid earnings announcement recently didn't do much to the stock price. We...

With a price-to-sales (or "P/S") ratio of 0.1x Reading International, Inc. ( NASDAQ:RDI ) may be sending bullish...

It's not a stretch to say that RPC, Inc.'s ( NYSE:RES ) price-to-earnings (or "P/E") ratio of 17.7x right now seems...

In October 2025, Geron Corporation announced a series of executive changes, including the departures of Andrew Grethlein, Ph.D., and Jim Ziegler, and the appointments of Ahmed ElNawawi as Chief Commercial Officer, Shanthakumar Tyavanagimatt as Chief Technical Officer, Dawn Schottlandt as SVP of Investor Relations and Corporate Affairs, and Bryan Ridgell as SVP of Portfolio and Project Management and Chief of Staff. These significant leadership transitions reflect the company’s intent to...

On October 13, 2025, Tvardi Therapeutics held a special call to provide an update on preliminary results from its Phase 2 REVERT trial evaluating a therapy for idiopathic pulmonary fibrosis. This update offers critical insight into the company’s research progress on a disease with limited treatment options and high unmet need. We’ll look at how the release of new clinical trial data frames Tvardi Therapeutics’ investment narrative and clinical development outlook. Rare earth metals are the...